跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-DESVENLAFAXINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-DESVENLAFAXINE
Authorized
STANDARD
TEVA-DESVENLAFAXINE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
12cb91c1ff5523c8
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
12cb91c1ff5523c8
Drug Approval Canada Name
TEVA-DESVENLAFAXINE
Product Name
TEVA-DESVENLAFAXINE
Status
Marketed
Status Date
2022-02-14
Original Market Date
2022-02-14
Din
02458217
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX23 DESVENLAFAXINE
Atc Name
n 06 ax 23
Aig Number
0152509001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
12cb91c1ff5523c8
Type
Standard
Back to Health Canada Approvals